Preoperative factors predicting lymphatic infiltration in colorectal cancer

Abstract

Abstract Colorectal cancer (CRC) is one of the most common malignancies worldwide, and accurate preoperative staging is essential for optimal surgical planning and oncologic outcomes. Lymph node (LN) metastasis is a key prognostic factor in CRC and plays a decisive role in treatment selection. The aim of this study was to evaluate the predictive value of preoperative imaging findings and laboratory parameters for LN metastasis in patients with CRC, in light of current literature. We retrospectively analyzed patients who underwent surgery for CRC between January 2015 and January 2021. Demographic data, tumor characteristics, preoperative laboratory results, and imaging findings obtained by computed tomography (CT) and magnetic resonance imaging (MRI) were reviewed. Postoperative pathological LN status was used as the reference standard, and all variables were statistically analyzed to identify factors associated with LN metastasis. A total of 410 patients were included in the study, of whom 58.3% were male. Lymph node metastasis was absent in 235 patients (N0), while 137 patients were classified as N1 and 38 as N2. Elevated preoperative carcinoembryonic antigen (CEA) levels (>5 ng/mL) were significantly associated with advanced nodal stage, with a higher proportion of N2 disease (p<0.05). Among tumor-related factors, lymphovascular invasion and neural invasion were found to be significantly associated with LN metastasis (p<0.05). The sensitivity, specificity, positive predictive value, and negative predictive value of CT in detecting LN metastasis were 58.19%, 55.49%, 47.97%, and 65.30%, respectively. In conclusion, LN metastasis should be strongly considered in CRC patients with elevated preoperative CEA levels and the presence of lymphovascular or neural invasion, particularly when supported by CT findings. These parameters may assist surgeons in preoperative risk stratification and treatment planning.

Keywords

• Colorectal Surgery;
• Lymph Node Dissection
• Lymph Node Metastasis
• Preoperative Assessment
• Surgical Oncology

Kolorektal kanserlerde lenfatik infiltrasyonu öngörmede preoperatif faktörler

Abstract

Giriş ve amaç Tüm dünyada ensık görülen kanser türlerinden olan kolorektal kanser (KRK) tedavisinde erken tanı ve tanı aşmasında evrelemenin doğru yapılabilmesi, tedavi kararı ve başarısı açısından önemlidir. Birçok kanser türünde sistemik enflamatuar yanıt göstergesi olan Nötrofil-lenfosit oranı (NLR) ve platelet-lenfosit oranının (PLR) preoperatif evreleme amacıyla kullanılmaktadır. KRK de lenfatik yayılım ve len nodu(LN) pozitifliği de tedavi kararı için önemli bir parametredir. Biz bu çalışmamızda KRK hastalarında preoperatif dönemde yapılan görüntülemelerin ve labarotuvar bulgularının LN metatsatzını öngörmedeki değerlerini saptamayı amaçladık. Materyal ve metod Ocak 2015-Ocak 2021 tarihleri arasında KRK nedeniyle opere edilen hastalar çalışmaya alındı. Hastaların demografik bilgileri, tümörlerine ait bilgileri, preoperatif bilgisayarlı tomografi (BT) ve manyetik rezonans (MR) görüntüleme bilgileri, preoperetif laboratuar bilgileri kayıt altına alındı. Postoperatif patoloji raporundaki LN metastazını önceden tahmin edilmesini belirlemek amacıyla tüm parametreler istatistiksel olarak değerlendirildi. P<0.05 değeri istatistiksel olarak anlamlı kabul edildi. Bulgular: Çalışmaya dahil edilen 410 hastanın 239’u (%58,3) erkek, 171’i (%41,7) kadındı. Çalışamaya dahil edilen hastaların 235’inde (%57,3) postoperatif patoloji raporuna göre LN metastazı saptanmadı (N0). LN metastazı olan hastaların 137’sinde N1, 38’inde N2 düzeyinde LN metastazı vardı. Karsinoembriyojenik antijen (CEA) değeri >5 olan hastalarda ise N0 evresinde olan hastaların yüzdesi %18,7 olarak saptanırken N2 evresinde olan hastaların oranı %44 olarak bulundu (p<0,05). LN metastazı varlığına etkisi olabilecek tümöral faktörlerden LVİ ve Nöral invazyonun LN metastazını anlamlı olarak arttırdığı saptanmıştır (p<0.05). BT’nin Ln metastazını saptamada duyarlılığı %58,19, özgüllüğü %55,49, pozitif doğruluk değeri %47,97, negatif doğruluk değeri %65,30 olarak saptanmıştır. Sonuç: Sonuç olarak KRK de preoepratif dönemde CEA değeri yüksek olan, LVİ olan ve Nİ olan hastalarda Bt ile de desteklenen durumlarda LN metastazı varlığı düşünülmelidir.

Keywords

• Kolorektal Cerrahi;
• Lenf Nodu Diseksiyonu
• Lenf Nodu Metastazi
• Ameliyat Öncesi Değerlendirme
• Cerrahi Onkoloji

References

1. 1 Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Translational Oncology 2021;14:101174.
2. 2 Vabi BW, Gibbs JF, Parker GS. Implications of the growing incidence of global colorectal cancer. J Gastrointest Oncol 2021;12: S387–S398.
3. 3 Ming-Sheng F, Mei-Ling D, Xun-Quan C, Yuan-Xin H, Wei-Jie Z, Qin-Cong P. Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and CEA as the Potential Prognostic Biomarkers for Colorectal Cancer. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1–9.
4. 4 Jin M, Frankel WL. Lymph Node Metastasis in Colorectal Cancer. Surgical Oncology Clinics of North America 2018;27:401–412.
5. 5 Todate Y, Honda M, Takada T, Saginoya T, Yamaguchi H, Hamada K, Nakayama Y, Kawamura H, Takano Y, Hashimoto K. The additional diagnostic impact of positron emission tomography–computed tomography for lymph node metastasis from colorectal cancer: A prospective lymph node level analysis. Journal of Surgical Oncology 2021;124:1085–1090.
6. 6 Uslu Biner İ, Ak Sivrikoz İ, İhtiyar E, Üstüner Z, Mutlu F. Kolorektal kanserlerin evrelemesinde F-18 FDG PET/BT’nin yeri / the role of F-18 FDG PET/CT in stagıng of colorectal cancers. Osmangazi J Med. 2016;38.
7. 7 İzbul T, Müderriszade M. (2003). KKTC’de kolorektal kanserli olguların retrospektif irdelenmesi. Akademik Gastroenteroloji Dergisi, 2(1). https://izlik.org/JA54TX28SJ.
8. 8 Canbay Durmaz, S. Kolorektal Kanserli Hastalarda Anatomik Lokalizasyona Bağlı Olarak Klinik Ve Patolojik Bulguların İncelenmesi, 2021.

9. 9 Katsoulis IE, Tzelves L, Lysikatou J, Karaitianos IG. Factors associated with lymph node retrieval in surgery for colorectal cancer. J BUON 2020;25:1854–1859.
10. 10 Newland RC, Chan C, Chapuis PH, et al. Relative effects of direct spread, lymph node metastasis and venous invasion in relation to blood borne distant metastasis present at the time of resection of colorectal cancer. Pathology 2020;52:649–656.
11. 11 Xie Y, Huang Y, Ruan Q, Wang H, Liang X, Hu Z, Li X. Impact of Tumor Site on Lymph Node Status and Survival in Colon Cancer. J Cancer 2019;10:2376–2383.
12. 12 Kudo S, Ichimasa K, Villard B, et al. Artificial Intelligence System to Determine Risk of T1 Colorectal Cancer Metastasis to Lymph Node. Gastroenterology 2021;160:1075-1084.e2.
13. 13 Ozyalvacli G, Yesil C, Kargi E, Kizildag B, Kilitci A, Yilmaz F. Diagnostic and prognostic importance of the neutrophil lymphocyte ratio in breast cancer. Asian Pac J Cancer Prev 2014;15:10363–10366.
14. 14 Stotz M, Gerger A, Eisner F, et al.Pancreatic cancer. Br J Cancer 2013;109:416–421.
15. 15 Gomez D, Farid S, Malik HZ, Young AL, Toogood GJ, Lodge JPA, Prasad KR. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 2008;32:1757–1762.
16. 16 Qian B-Z. Inflammation fires up cancer metastasis. Seminars in Cancer Biology 2017;47:170–176.
17. 17 Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005;91:181–184.
18. 18 Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ, Lodge JPA. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 2008;34:55–60.
19. 19 Kim H, Jung HI, Kwon SH, Bae SH, Kim HC, Baek M-J, Lee MS. Preoperative neutrophil-lymphocyte ratio and CEA is associated with poor prognosis in patients with synchronous colorectal cancer liver metastasis. Ann Surg Treat Res 2019;96:191.
20. 20 Zhan X, Xiaobo Sun, Hong Y, Wang Y, Ding K. Combined Detection of Preoperative Neutrophil-to-Lymphocyte Ratio and CEA as an Independent Prognostic Factor in Nonmetastatic Patients Undergoing Colorectal Cancer Resection Is Superior to NLR or CEA Alone. BioMed Research International 2017;2017:1–10.
21. 21 Bukowski J, Góźdź S, Słuszniak J, Kowalski D, Zagała A, Korejba W, Banasińska E. Carcino-embryonic antigen (CEA) in the serum of patients with cancer of the colon and rectum. Nowotwory 1986; 36: 181–186.
22. 22 Albanopoulos K, Armakolas A, Konstadoulakis MM, et al. Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer. Am J Gastroenterol 2000; 95: 1056–1061.
23. 23 Ye H, Zheng B, Zheng Q, Chen P. Influence of Old Age on Risk of Lymph Node Metastasis and Survival in Patients With T1 Colorectal Cancer: A Population-Based Analysis. Front Oncol 2021;11:706488.
24. 24 Nikberg M, Chabok A, Letocha H, Kindler C, Glimelius B, Smedh K. Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry. Acta Oncologica 2016;55:1418–1424.
25. 25 Wu G, Liu J-G, Huang X-L, Wei C-Y, Jeen Pc F, Xie W-S, Chen S-M, Zhang C-Q, Tang W-Z. A nomogram for preoperative prediction of lymphatic infiltration in colorectal cancer: A personalized approach to clinical decision making. Medicine 2019;98:e18498.
26. 26 Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N, Berger DH, Albo D. Perineural Invasion Is an Independent Predictor of Outcome in Colorectal Cancer. JCO 2009;27:5131–5137.
27. 27 Onate-Ocana LF, Montesdeoca R, Lopez-Graniel CM, et al. Identification of Patients with High-risk Lymph Node-negative Colorectal Cancer and Potential Benefit from Adjuvant Chemotherapy. Japanese Journal of Clinical Oncology 2004;34:323–328.
28. 28 Liebl F, Demir IE, Rosenberg R, et al. The Seve-rity of Neural Invasion Is Associated with Shortened Survival in Colon Cancer. Clinical Cancer Research 2013;19:50–61.
29. 29 Rollvén E, Blomqvist L, Öistämö E, Hjern F, Csanaky G, Abraham-Nordling M. Morphologi-cal predictors for lymph node metastases on computed tomography in colon cancer. Abdom Radiol 2019;44:1712–1721.
30. 30 Brown G, Richards CJ, Bourne MW, et al. Morphologic Predictors of Lymph Node Status in Rectal Cancer with Use of High-Spatial-Resolution MR Imaging with Histopathologic Comparison. Radiology 2003;227:371–377.
31. 31 Nerad E, Lahaye MJ, Maas M, Nelemans P, Bakers FCH, Beets GL, Beets-Tan RGH. Diagnostic Accuracy of CT for Local Staging of Colon Cancer: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol 2016;207:984–995.
32. 32 Bedrikovetski S, Dudi-Venkata NN, Kroon HM, et al. Artificial intelligence for pre-operative lymph node staging in colorectal cancer: a systematic review and meta-analysis. BMC Cancer 2021;21:1058.
33. 33 Kijima S, Sasaki T, Nagata K, Utano K, Lefor AT, Sugimoto H. Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT. World J Gastroenterol 2014;20:16964–16975.
34. 34 Choi J, Oh SN, Yeo D-M, Kang WK, Jung C-K, Kim SW, Park MY. Computed tomography and magnetic resonance imaging evaluation of lymph node metastasis in early colorectal cancer. World J Gastroenterol 2015;21:556–562.
35. 35 Ricciardi R, Madoff RD, Rothenberger DA, Baxter NN. Population-Based Analyses of Lymph Node Metastases in Colorectal Cancer. Clinical Gastroenterology and Hepatology 2006; 4: 1522–1527.
36. 36 Shen SS, Haupt BX, Ro JY, Zhu J, Bailey HR, Schwartz MR. Number of Lymph Nodes Examined and Associated Clinicopathologic Factors in Colorectal Carcinoma. Archives of Pathology & Laboratory Medicine 2009;133:781–786.
37. 37 Ballanamada Appaiah NN, Rafaih Iqbal M, Kafayat Lesi O, et al. Clinicopathological Factors Affecting Lymph Node Yield and Positivity in Left-Sided Colon and Rectal Cancers. Cureus (e-pub ahead of print 29 October 2021; doi:10.7759/cureus.19115).